Publication | Open Access

(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Medicinal ChemistryBiochemistryMedicineNatural SciencesType 2Mechanism Of ActionPharmacological AgentPharmacotherapyDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery